Corresponding to the DMSO group, we performed transient overexpression of BCLAF1-WT or BCLAF1-mSBC in SPOP-overexpressing HCC cell lines in the Atezolizumab group, respectively. Here, SPOP is linked to hepatocellular carcinoma.